Sort by
Refine Your Search
-
Listed
-
Country
-
Field
-
), Blood Cancer Journal (2022), Cell Stem Cell (2018). The Li research program is supported by multiple NIH (R01s), American Cancer Society, The Alex’s Lemonade Stand Foundation and several other prestigious
-
to provide a more integrated picture of life processes in the context of health and disease. To be a postdoc fellow at the AMBER programme you will get unprecedented medical, biological, and methodological
-
Wellbeing Across Lifespan (SWAN) brings together expertise from the fields of medicine, life sciences, social sciences as well as computer and computational sciences to promote scientific and societal impact
-
possible. We strive to ensure the diversity of our candidates, and we reflect this ethos in the way we promote the ICRF programme and in our recruitment and selection process. Imperial’s diversity networks
-
pipelines, proficiency in genomic association analyses, particularly involving large-scale datasets, and familiarity with cloud computing and/or high-performance computing (HPC) environments
-
the intersection of computer science and drug research, to support strategic focus on the use of AI in scientific research within the general area related to drug security. The position is at
-
. This collaboration fosters a strong interdisciplinary environment across institutions, leveraging complementary expertise in statistical genetics, biomedical data integration, and computational method development
-
of the Quadram Early Career Fellowship programme are for the successful candidates to: • Initiate an independent research programme at QIB to generate preliminary data in support of fellowship applications
-
creative Postdoctoral Fellow to join our multidisciplinary team dedicated to investigating the causes and consequences of somatic mutations in cancer. Our lab integrates cutting-edge computational and
-
research clinicians concerned with both basic immunological principles and understanding the immune response through treatment. The post holder will be based within the largest CAR T cell program in Europe